Ignite Creation Date:
2025-12-26 @ 11:47 AM
Ignite Modification Date:
2026-02-24 @ 3:14 PM
Study NCT ID:
NCT00289016
Status:
COMPLETED
Last Update Posted:
2015-12-18
First Post:
2006-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma
Sponsor:
BioVex Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
002/03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |